The FDA approved a prefilled syringe format for Ani's purified Cortrophin Gel that should ease administration for MS patients ...
Operator Good morning, and welcome to Ocugen's fourth quarter and full-year 2024 financial results and business update.
Q4 2024 Earnings Call Transcript March 5, 2025 Ocugen, Inc. reports earnings inline with expectations. Reported EPS is $-0.05 ...
Thimerosal-allergic patients were challenged with three intramuscular injections of thimerosal solution (100 µg/mL) into the arm; if no reaction was observed, the dosage was increased (to 0.1 mL ...
In each arm, participants will be randomized in a ... using one-fifth the dose compared to the same vaccine administered intramuscular. The Phase 1 clinical trial is anticipated to start in ...
The approval was based on data from a randomized, double-blind, placebo-controlled phase 3 trial (ClinicalTrials.gov Identifier: NCT05072080) that compared the safety and immunogenicity of a single ...
28 29 Non-surgical management options for EIN include treatment with progestin therapy, either with a levonorgestrel intrauterine device, oral progestins, intramuscular injections ... The carboplatin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback